Nutanix vs UiPath
Add, change or remove companies; up to four.
The short version
- Nutanix is the larger business, with $2.9B of revenue in fiscal 2026 against $1.6B for UiPath, about 1.8 times as much.
- Nutanix kept more of each dollar of sales as operating profit (9.6% operating margin, against 3.5%).
- Nutanix turned more of its sales into free cash flow (29.5% FCF margin, against 21.9%).
| Latest fiscal year | NTNX Β· FY26 | PATH Β· FY26 |
|---|---|---|
| Size | ||
| Market cap | β | $7.4B |
| Revenue | $2.9B | $1.6B |
| Free cash flow | $841M | $352M |
| Net income | $1.5B | $282M |
| Growth | ||
| Revenue growth | 12.4% | 12.7% |
| 5-year growth | 15.4% | 21.5% |
| Share count change | β | β2.7% |
| Profitability | ||
| Gross margin | 86.8% | 83.2% |
| Operating margin | 9.6% | 3.5% |
| Net margin | 52.8% | 17.5% |
| FCF margin | 29.5% | 21.9% |
| Return on capital | β | 13.7% |
| Return on equity | β | 14.4% |
| Balance sheet | ||
| Net debt | β$1.0B | β$1.5B |
| Net debt / EBITDA | β2.9x | β20.0x |
| Dividends and buybacks | $484M | $329M |
| Valuation & quality | ||
| P/E | β | 21.1x |
| Piotroski F-score | β | 7 |
FY17
NTNX $846M
PATH β
FY18
NTNX $1.2B
PATH β
FY19
NTNX $1.2B
PATH β
FY20
NTNX $1.3B
PATH $336M
FY21
NTNX $1.4B
PATH $608M
FY22
NTNX $1.6B
PATH $892M
FY23
NTNX $1.9B
PATH $1.1B
FY24
NTNX $2.1B
PATH $1.3B
FY25
NTNX $2.5B
PATH $1.4B
FY26
NTNX $2.9B
PATH $1.6B
NTNX
PATH
FY17
NTNX β41.2%
PATH β
FY18
NTNX β24.3%
PATH β
FY19
NTNX β48.4%
PATH β
FY20
NTNX β63.4%
PATH β153.9%
FY21
NTNX β47.5%
PATH β18.2%
FY22
NTNX β29.0%
PATH β56.1%
FY23
NTNX β11.1%
PATH β32.9%
FY24
NTNX 0.4%
PATH β12.6%
FY25
NTNX 6.8%
PATH β11.4%
FY26
NTNX 9.6%
PATH 3.5%
NTNX
PATH
FY17
NTNX β$35.4M
PATH β
FY18
NTNX $30.2M
PATH β
FY19
NTNX β$76.3M
PATH β
FY20
NTNX β$249M
PATH β$375M
FY21
NTNX β$158M
PATH $27.2M
FY22
NTNX $18.5M
PATH β$63.8M
FY23
NTNX $207M
PATH β$33.8M
FY24
NTNX $598M
PATH $292M
FY25
NTNX $750M
PATH $306M
FY26
NTNX $841M
PATH $352M
NTNX
PATH
FY17
NTNX β
PATH β
FY18
NTNX β
PATH β
FY19
NTNX β
PATH β
FY20
NTNX β
PATH β
FY21
NTNX β
PATH β
FY22
NTNX β
PATH β
FY23
NTNX β
PATH β
FY24
NTNX β
PATH β
FY25
NTNX β
PATH β
FY26
NTNX β
PATH 13.7%
NTNX
PATH
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.